INFORMATION BY CANCER TYPE
Immunotherapy agents have their own set of side effects, and managing them quickly and efficiently is key.
How and why I've chosen to live my cancer in the public eye.
Growing scientific insights have led to the swift development of treatments for advanced melanoma, leaving doctors to iron out details about their application.
The role of immunotherapies and targeted treatments in lung cancer is evolving at breakneck speed.
Keytruda improved quality of life for patients with lung cancer in a recent trial.
Melanoma should not be considered to be in a "special category" that responds well to immunotherapy, according to Christian M. Capitini, M.D., assistant professor of Pediatrics at the University of Wisconsin.
Immunotherapy continues to advance in melanoma and other solid tumor types as new combinations and biomarkers are being explored.
Keytruda Granted a Priority Review by the FDA for Advanced Microsatellite Instability-High (MSI-H) Cancer
Keytruda may be a viable treatment option for patients with advanced microsatellite instability-high cancer in the future.
The future of multiple myeloma treatment may be in immunotherapy combinations, according to Eric L. Smith, M.D., Ph.D.
A cancer diagnosis comes served up with a slew of side effects. While many can be anticipated and managed, some cannot. They can crop up unexpectedly and take up residence indefinitely.